Kerlan V, Dreano Y, Bercovici J P, Beaune P H, Floch H H, Berthou F
Laboratoire de Biochimie, Faculté de Médecine, Brest, France.
Biochem Pharmacol. 1992 Nov 3;44(9):1745-56. doi: 10.1016/0006-2952(92)90068-t.
Kinetics of the 2- and 4-hydroxylations of estradiol (E2) by human liver microsomal samples were studied to determine the major P450 isoform involved in these endogenous reactions. Thirty human liver microsomal samples were analysed. Metabolism of 25 microM [14C]E2 produced 2-hydroxy and 4-hydroxy derivatives with a ratio of 3.2 +/- 1.5 and a great inter-individual variation. Kinetic analysis of the 2- and 4-hydroxylations of E2 exhibited a curvilinear double reciprocal plot with an apparent Km of 15 microM. Further experiments demonstrated that alpha-naphthoflavone, testosterone and progesterone increased the 2-hydroxylation activity, suggesting the involvement of a substrate activation mechanism. These two hydroxylations of E2 were shown to be catalysed by cytochrome P450 with an apparent dissociation constant Ks of 0.8 microM. These 2- and 4-hydroxylations inter-correlated significantly (r = 0.93; N = 30). The 2-hydroxylation of E2 correlated with four monooxygenase activities known to be supported by P450 3A4/3A5, namely nifedipine oxidation (r = 0.78; N = 29); erythromycin N-demethylation (r = 0.69; N = 27), testosterone 6 beta-hydroxylation (r = 0.66; N = 25) and tamoxifen N-demethylation (r = 0.64; N = 29). On the other hand, E2-hydroxylations did not correlate with activities supported by P450 1A2 and P450 2E1. Furthermore, drugs as cyclosporin, diltiazem, triacetyl-oleandomycin and 17 alpha-ethynylestradiol inhibited more than 90% of the E2-hydroxylations at concentrations < 250 microM, while weak inhibition was shown with 500 microM cimetidine and no significant inhibition with caffeine, phenacetin and omeprazole. Finally, 2- and 4-hydroxylations of E2 correlated significantly with the content of P450 3A4/3A5 immunodetected by a monoclonal antibody anti-human P450-nifedipine (r = 0.84; N = 28). E2-hydroxylation activities were inhibited by more than 80% with polyclonal anti-human anti-P450-nifedipine. Preincubation of human liver microsomes with 100 microM gestodene (a suicide substrate of P450 3A4) inactivated this P450 isoform and accordingly allowed evaluation of the contribution of other P450 isoforms to the E2 metabolism to about 21% (+/- 17%, N = 29). All these results taken together suggest that P450 3A4/3A5 are the major forms involved in the formation of catecholestrogens in the human liver microsomes.
研究了人肝微粒体样品对雌二醇(E2)进行2-和4-羟化反应的动力学,以确定参与这些内源性反应的主要细胞色素P450同工酶。分析了30份人肝微粒体样品。25微摩尔[14C]E2的代谢产生了2-羟基和4-羟基衍生物,其比例为3.2±1.5,个体间差异很大。对E2的2-和4-羟化反应的动力学分析显示,双倒数图呈曲线,表观Km为15微摩尔。进一步的实验表明,α-萘黄酮、睾酮和孕酮增加了2-羟化活性,提示存在底物激活机制。E2的这两种羟化反应显示由细胞色素P450催化,表观解离常数Ks为0.8微摩尔。这两种2-和4-羟化反应显著相互关联(r = 0.93;N = 30)。E2的2-羟化反应与已知由P450 3A4/3A5支持的四种单加氧酶活性相关,即硝苯地平氧化(r = 0.78;N = 29);红霉素N-去甲基化(r = 0.69;N = 27)、睾酮6β-羟化(r = 0.66;N = 25)和他莫昔芬N-去甲基化(r = 0.6,4;N = 29)。另一方面,E2-羟化反应与由P450 1A2和P450 2E1支持的活性无关。此外,环孢素、地尔硫䓬、三乙酰竹桃霉素和17α-乙炔雌二醇等药物在浓度<250微摩尔时抑制E2-羟化反应超过90%,而500微摩尔西咪替丁显示出弱抑制作用,咖啡因、非那西丁和奥美拉唑无显著抑制作用。最后,E2的2-和4-羟化反应与用抗人P450-硝苯地平单克隆抗体免疫检测到的P450 3A4/3A5含量显著相关(r = 0.84;N = 28)。用多克隆抗人抗P450-硝苯地平抗体可使E2-羟化活性抑制超过80%。用人肝微粒体与100微摩尔孕二烯酮(P450 3A4的自杀底物)预孵育可使该P450同工酶失活,从而可评估其他P450同工酶对E2代谢的贡献约为21%(±17%,N = 29)。综合所有这些结果表明,P450,3A4/,3A5是参与人肝微粒体中儿茶酚雌激素形成的主要形式。